OpenPV Signal Explorer
FAERS disproportionality dashboard
← All drugs
Drug

Calcipotriene

150 flagged reaction(s) · 5,477 total co-reports · max PRR 34.1
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Psoriasis 740 34.1 42.9 signal
2 Psoriatic Arthropathy 137 20.5 21.3 signal
3 Diabetes Mellitus Inadequate Control 59 20.0 20.3 signal
4 Therapeutic Product Effect Incomplete 145 12.3 12.8 signal
5 Treatment Failure 122 8.9 9.2 signal
6 Squamous Cell Carcinoma 14 8.9 8.9 signal
7 Skin Exfoliation 123 8.9 9.2 signal
8 Therapy Non-responder 63 8.5 8.6 signal
9 Dermatitis Contact 16 8.4 8.5 signal
10 Skin Fissures 26 8.3 8.3 signal
11 Rebound Effect 15 7.9 8.0 signal
12 Skin Lesion 36 7.9 8.0 signal
13 Depressed Mood 65 7.4 7.5 signal
14 Cognitive Disorder 49 6.3 6.4 signal
15 Basal Cell Carcinoma 16 6.1 6.2 signal
16 Rotator Cuff Syndrome 12 5.6 5.6 signal
17 Therapy Partial Responder 14 5.6 5.6 signal
18 Medication Error 51 5.5 5.6 signal
19 Contusion 87 5.4 5.5 signal
20 Skin Haemorrhage 13 5.4 5.4 signal
21 Poor Quality Product Administered 9 5.3 5.3 signal
22 Treatment Noncompliance 47 5.2 5.2 signal
23 Economic Problem 13 5.1 5.1 signal
24 Pharyngitis Streptococcal 9 5.0 5.0 signal
25 Amnesia 53 4.9 4.9 signal
26 Sleep Disorder Due To A General Medical Condition 13 4.8 4.8 signal
27 Ovarian Cyst 8 4.8 4.8 signal
28 Mobility Decreased 56 4.7 4.7 signal
29 Folliculitis 8 4.6 4.6 signal
30 Tenderness 8 4.6 4.6 signal
31 Joint Stiffness 20 4.6 4.6 signal
32 Anhedonia 20 4.5 4.5 signal
33 Intervertebral Disc Degeneration 7 4.5 4.5 signal
34 Joint Range Of Motion Decreased 10 4.5 4.5 signal
35 Bursitis 9 4.5 4.5 signal
36 Sinus Congestion 10 4.4 4.4 signal
37 Coordination Abnormal 10 4.3 4.3 signal
38 Ankle Fracture 11 4.3 4.3 signal
39 Hepatic Cirrhosis 13 4.2 4.2 signal
40 Neoplasm 8 4.2 4.2 signal
41 Nodule 9 4.1 4.1 signal
42 Drug Ineffective For Unapproved Indication 38 4.1 4.1 signal
43 Application Site Pain 15 4.1 4.1 signal
44 Abdominal Discomfort 113 4.0 4.2 signal
45 Upper Respiratory Tract Infection 31 4.0 4.1 signal
46 Gallbladder Disorder 12 4.0 4.0 signal
47 Wound 18 3.9 3.9 signal
48 Product Use In Unapproved Indication 158 3.9 4.0 signal
49 Drug Ineffective 832 3.8 4.7 signal
50 Rash Pruritic 34 3.8 3.8 signal
51 Dermatitis 13 3.8 3.8 signal
52 Device Defective 10 3.7 3.7 signal
53 Stress 44 3.7 3.7 signal
54 Pulmonary Mass 9 3.6 3.6 signal
55 Product Dose Omission 40 3.6 3.6 signal
56 Malignant Melanoma 8 3.6 3.6 signal
57 Quality Of Life Decreased 8 3.6 3.6 signal
58 Motor Dysfunction 6 3.6 3.6 signal
59 Product Prescribing Issue 12 3.5 3.5 signal
60 Eczema 29 3.5 3.5 signal
61 Skin Laceration 6 3.3 3.3 signal
62 Rash Erythematous 26 3.3 3.3 signal
63 Peripheral Swelling 85 3.3 3.4 signal
64 Sinusitis 56 3.3 3.3 signal
65 Skin Irritation 25 3.3 3.3 signal
66 Immunodeficiency 8 3.3 3.3 signal
67 Nerve Compression 5 3.3 3.3 signal
68 Skin Disorder 18 3.2 3.3 signal
69 Tendonitis 8 3.1 3.1 signal
70 Drug Eruption 9 3.1 3.1 signal
71 Arthralgia 209 3.0 3.1 signal
72 Drug Effect Less Than Expected 7 3.0 3.0 signal
73 Photosensitivity Reaction 8 2.9 2.9 signal
74 Fungal Infection 16 2.9 2.9 signal
75 Discomfort 29 2.9 2.9 signal
76 Pruritus 180 2.9 3.0 signal
77 Insurance Issue 7 2.8 2.8 signal
78 Rash Macular 16 2.8 2.8 signal
79 Erythema 94 2.7 2.8 signal
80 Rash 198 2.7 2.8 signal
81 Application Site Erythema 12 2.7 2.7 signal
82 Sars-cov-2 Test Positive 6 2.7 2.7 signal
83 Product Dose Omission Issue 127 2.7 2.7 signal
84 Rash Papular 10 2.7 2.7 signal
85 Drug Effective For Unapproved Indication 13 2.7 2.7 signal
86 Dermatitis Atopic 22 2.6 2.6 signal
87 Conjunctivitis 8 2.6 2.6 signal
88 Migraine 41 2.6 2.6 signal
89 Road Traffic Accident 18 2.6 2.6 signal
90 Diarrhoea Haemorrhagic 4 2.6 2.6 no signal
91 Nephropathy 4 2.6 2.6 no signal
92 Impaired Quality Of Life 6 2.5 2.5 no signal
93 Therapeutic Response Decreased 25 2.5 2.5 signal
94 Frequent Bowel Movements 11 2.4 2.5 signal
95 Pain Of Skin 11 2.4 2.4 signal
96 Hip Arthroplasty 6 2.4 2.4 no signal
97 Product Administered At Inappropriate Site 7 2.3 2.3 no signal
98 Skin Burning Sensation 27 2.3 2.3 signal
99 Respiratory Tract Congestion 6 2.3 2.3 no signal
100 Dry Skin 49 2.2 2.2 signal
101 Body Height Decreased 4 2.2 2.2 no signal
102 Contraindicated Product Administered 11 2.2 2.2 signal
103 Oral Herpes 7 2.2 2.2 no signal
104 Arthropathy 20 2.1 2.2 signal
105 Sneezing 8 2.1 2.1 no signal
106 Panic Attack 13 2.1 2.1 signal
107 Hyperthyroidism 5 2.1 2.1 no signal
108 Retinal Detachment 3 2.0 2.0 no signal
109 Skin Cancer 7 1.9 1.9 no signal
110 No Therapeutic Response 4 1.9 1.9 no signal
111 Product Complaint 8 1.9 1.9 no signal
112 Therapeutic Product Effect Decreased 14 1.9 1.9 no signal
113 Laceration 3 1.9 1.9 no signal
114 Affect Lability 3 1.9 1.9 no signal
115 Inflammatory Bowel Disease 3 1.8 1.8 no signal
116 Expired Product Administered 10 1.8 1.8 no signal
117 Drug Effect Incomplete 11 1.8 1.8 no signal
118 Injection Site Warmth 6 1.7 1.7 no signal
119 Injection Site Discomfort 3 1.7 1.7 no signal
120 Drug Effect Decreased 15 1.6 1.6 no signal
121 Bipolar Disorder 3 1.6 1.6 no signal
122 Emotional Distress 32 1.6 1.6 no signal
123 Hallucination, Auditory 4 1.5 1.5 no signal
124 Muscle Spasticity 3 1.4 1.4 no signal
125 Injection Site Irritation 3 1.4 1.4 no signal
126 Tuberculosis 3 1.4 1.4 no signal
127 Ankylosing Spondylitis 3 1.4 1.4 no signal
128 Application Site Pruritus 5 1.3 1.3 no signal
129 Therapeutic Response Shortened 7 1.3 1.3 no signal
130 Intentional Self-injury 4 1.2 1.2 no signal
131 Acne 15 1.2 1.2 no signal
132 Device Malfunction 13 1.2 1.2 no signal
133 Injection Site Bruising 15 1.1 1.1 no signal
134 Drug Dose Omission 31 1.1 1.1 no signal
135 Injection Site Haemorrhage 14 1.1 1.1 no signal
136 Injection Site Reaction 12 1.0 1.0 no signal
137 Abortion Spontaneous 7 1.0 1.0 no signal
138 Injection Site Mass 6 1.0 1.0 no signal
139 Device Issue 14 1.0 1.0 no signal
140 Injection Site Erythema 19 0.9 0.9 no signal
141 Product Storage Error 13 0.9 0.9 no signal
142 Injection Site Pain 44 0.9 0.9 no signal
143 Wrong Technique In Drug Usage Process 5 0.8 0.8 no signal
144 Exposure Via Skin Contact 3 0.8 0.8 no signal
145 Injection Site Rash 4 0.8 0.8 no signal
146 Injection Site Urticaria 3 0.7 0.7 no signal
147 Injection Site Pruritus 8 0.7 0.7 no signal
148 Device Leakage 5 0.7 0.7 no signal
149 Accidental Exposure To Product 11 0.7 0.7 no signal
150 Bladder Cancer 3 0.3 0.3 no signal